Advertisement

Topics

MS Pharma ink deal for acquisition of Genepharm http://bit.ly/2Gkat4F  #pharmapic.twitter.com/pkPgmAHGEa

06:48 EDT 17 Apr 2019 | Pharmafile

MS Pharma ink deal for acquisition of Genepharm http://bit.ly/2Gkat4F 

Original Article: MS Pharma ink deal for acquisition of Genepharm http://bit.ly/2Gkat4F  #pharmapic.twitter.com/pkPgmAHGEa

NEXT ARTICLE

More From BioPortfolio on "MS Pharma ink deal for acquisition of Genepharm http://bit.ly/2Gkat4F  #pharmapic.twitter.com/pkPgmAHGEa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...